You can use the message in end of the article abstract to
cite it.
To get Microsoft Documents: After you open the "Full Text" for each
article, change the last 3 characters of the web address from .pdf
to .doc (or .docx)
When you submit manuscript(s),
please mention that it is submitted to the Cancer Biology.
Marsland
Press,
PO Box 180432, Richmond Hill, New York 11418, USA, 347-321-7172
http://www.cancerbio.net
CONTENTS
No.
|
Titles /
Authors /Abstracts
|
Full Text
|
No.
|
1
|
In Silico Molecular Classification of Breast and Prostate
Cancers using Back Propagation Neural Network
Zahraa Naser Shahweli1, Ban Nadeem Dhannoon2,
Rehab S. Ramadhan3
1.
Computer Science Department, College of Science, Al-Nahrain
University, Baghdad, Iraq,
Stcs-zns16@sc.nahrainuniv.edu.iq
2.
Computer Science Department, College of Science, Al-Nahrain
University, Baghdad, Iraq,
bnt@sc.nahrainuniv.edu.iq
3.
Medical Biotechnology Department, College of biotechnology, Al-Nahrain
University, Baghdad, Iraq, rehabrebah@biotech.nahrainuniv.edu.iq
Abstract:
Cancer is a standout amongst the most widely recognized and
complex infections of the present century since it happens
because of numerous organic and physical responses. One of the
amplest and most boundless growths for the ladies today is
Breast tumor, while prostate malignancy is a worry for some men.
Computational models of disease are being created to help both
biological invention and clinical prescription. The In silico
models encourage the accumulation and utilization of trials to
break down and separate rich organic data from vast natural
database. In this study, a total of seven data sets is used,
that is, five data sets from the Universal Mutation Database (UMD)
TP53 database and two datasets from the
International Agency
for Research on Cancer (IARC)
TP53 database, are used to assess the work. Back propagation
neural network with hybrid model of 5-fold cross-validation and
validation sets was used to classify and predict breast and
prostate cancers in patients based on molecular mutations
located in the TP53 gene. The performance of the proposed system
in the network testing phase was determined to be satisfactory
based on the average values for all folds of five indices (i.e.,
sensitivity = 97 and 96.5; specificity = 96.6 and 97.3; accuracy
= 98 and 96.7; F-measure = 98.1 and 97.1; and Matthew’s
correlation coefficient = 0.93 and 0.91) for breast and prostate
cancers, respectively.
[In Silico Molecular
Classification of Breast and Prostate Cancers using Back
Propagation Neural Network.
Zahraa Naser Shahweli, Ban Nadeem Dhannoon, Rehab S. Ramadhan.
Cancer Biology
2017;7(3):1-7].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
1.
doi:10.7537/marscbj070317.01.
Keywords:
Classification; Back Propagation Neural Network; Cross
Validation; Validation Set; TP53 gene; in silico; Breast Cancer;
Prostate Cancer. |
Full Text |
1
|
2
|
Anti-cancer activity of
Crinum defixum
Ker-Gawler medicinal plant leaves
using KB cells
*A.
Elaiyaraja, G.
Chandramohan
Department of Chemistry, A.V.V.M. Sri Pushpam College, Poondi,
Thanjavur-613 503, Tamilnadu, India.
Emails:
raja_mscchem@rediffmail.com,
Mobile: 9043571103
Abstract:
Crinum defixum
Ker-Gawler
is a well-known herb used in ethnomedicine. Alakaloids and
flavonoids are major constituents of C.defixum.
In this study, we investigated the anticancer activity of
KB and normal HGF-1 cells.
We demonstrated the effects of ethanolic extract
of C.defixum
on the cell growth and
apoptosis in
KB and normal HGF-1
cells were
analyzed by the generation of reactive oxygen species (ROS), the
level of
mitochondrial
membrane potential (∆ψM)
and apoptotic morphological changes were analyzed by AO/EtBr, AO
and Hoechst staining. Our results indicated that
the ethanolic extracts of C.defixum shows better
anticancer activity through it’s induces increased cell death,
ROS generation, alteration of mitochondria membrane potential
and apoptosis.
[A.
Elaiyaraja, G.
Chandramohan. Anti-cancer
activity of Crinum defixum Ker-Gawler medicinal plant
leaves using KB cells.
Cancer Biology
2017;7(3):8-13].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
2.
doi:10.7537/marscbj070317.02.
Keywords:
Crinum defixum
Ker-Gawler,
Anticancer
activity, KB, normal HGF-1 cell,
ROS generation, Mitochondria membrane
potential. |
Full Text |
2
|
3
|
The use of magnetic
nanoparticles in hyperthermia of Ehrlich tumor
Sahar E. Abo-Neima1,
Hussein A. Motaweh1, and Rahma M.Anany1
1Department
of physics, Faculty of Science, Damanhur University, Egypt.
Sahar_amr2002@yahoo.com
Abstract:
Hyperthermia has been in use for
many years, as a potential alternative method in cancer
treatment, and high frequency microwave radiation has been used
successfully to raise the tumor temperature to around 42oC
in superficial tumors without causing damage to surrounding
healthy tissues. In the present work a total of 60 male mice
weighing 20-25gm of 4-5 weeks of age will be used in all the
experiments. A suspension of 106 cells/ mL isolated
from Ehrlich ascites carcinoma in mice will be prepared. The
animals will be injected into the left flank with 0.2mL of this
suspension. When tumors reach approximately 5-10 mm in diameter,
mice will be randomly divided into nine groups, each of ten
namely from G1 to G9:1st group
which injected with phosphate buffer (control group). 2nd
group which mice bearing tumor without injection with magnetic
nanoparticles (MNPs) and without hyperthermia (Tumor).3rd
group which mice bearing tumor exposed to microwave
hyperthermia without injection of MNPs (MW). 4th
group which mice bearing tumor injected with ferric MNPs (FE)
without hyperthermia.5th group which mice bearing
tumor injected with ferric MNPs and exposed to microwave
hyperthermia (FE+MW). 6th group which mice bearing
tumor injected with Nickel MNPs without hyperthermia (NI).7th
group which mice bearing tumor injected with MNPs and exposed to
microwave hyperthermia (NI+MM).8thgroup which mice
bearing tumor injected with MNPs without hyperthermia (CO).9th
group which mice bearing tumor injected with cobalt MNPs and
exposed to microwave hyperthermia (CO+MW). The results showed
that The transmission electron microscope (TEM) image shows that
the prepared magnetite nanoparticles are almost spherical shape.
The particles have tendency to aggregate because of their
magnetic properties. The average particle size as determine from
the histogram is ~ 20 nm for Fe and 100nm for Co and Ni. The
electron diffraction shows that the sample are completely
crystalline as confirmed from the x-ray diffraction (XRD) and
there was highly significant decreased in the normalized tumor
size with the different treatment modalities as compared with
the animal bearing tumor (control group). The very high
significant decreased for Ni+MW treatment was indicated i.e. the
treatment of ehrlich tumor with Ni+MW give us the most
inhibition for tumor size. From the histopathological study for
ehlich tumor where tumors were treated with MNPs and with NPs
+MW which exhibits tumor necrosis and fibrosis. It was concluded
that MNPs can penetrate tumor tissue and pass through gaps, are
able to remain in the tumor tissue and destroyed cancer cells.
[Sahar
E. Abo-Neima, Hussein A. Motaweh, and Rahma M. Anany.
The use of magnetic nanoparticles in hyperthermia of Ehrlich
tumor.
Cancer Biology
2017;7(3):14-20].
ISSN:
2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
3.
doi:10.7537/marscbj070317.03.
Keywords:
Ehlich tumor, microwave, nanoparticles, TEM, XRD, histopathology |
Full Text |
3
|
4
|
Comparison between
Male Breast Cancer and Female Breast Cancer, Retrospective Study
Rehab F Mohamed
Department of Clinical Oncology and Nuclear Medicine, Faculty of
Medicine, Assiut University, Assiut, Egypt
faroukrehab@yahoo.com
Abstract: Background
Male breast cancer (MBC) is a rare disease compared to female
breast cancer (FBC). It accounts less than 1% of all breast
cancer and less than 1% of all men cancer. Male patients with
breast cancer are treated according to treatment guidelines of
FBC specifically the guidelines of post-menopausal FBC
based on the high expression of estrogen receptor (ER) which
found in the tumor of MBC and post-menopausal FBC patients and
low estrogen expression in their
bodies.
In this retrospective study, we aimed to compare MBC to FBC to
understand the biological behavior of MBC and the outcome of
this disease.
Patients and methods
Patients diagnosed between
2005-2012 with breast cancer were included in this study, their
number was 477 cases. Patients were classified according to sex
into male (number=17) and female (number=460) breast cancer. We
compared the
incidence, tumor characters, adjuvant treatment, the 5-years disease free
survival (DFS), and Overall survival (OS) of MBC to FBC.
Results
MBC cases were 3.6% compared to 96.4% FBC cases which were
highly significant. As regarding to the stage of the tumor at
diagnosis, no differences were seen between MBC and FBC,
82.4%stage I & II for MBC versus 77.4% for FBC and 17.3% stage
III & IV for MBC versus 22.6% for FBC. No significant difference
between MBC and FBC as regarding the type of pathology, ductal
carcinoma in situ (DCIS) was found in 5.9% versus 1.3%, invasive
ductal carcinoma (IDC) was found in 94.1% versus 96.7%, and
invasive lobular carcinoma was found in 2% of FBC only. Most of
patients expressed positive estrogen receptor (ER), 88.2% for
MBC versus 75% in FBC (P<0.04) while 70.6% of MBC were
progesterone receptor (PR) positive versus 71.1% in FBC. As
regarding to HER2/neu status 23.5% was positive in MBC versus
66.7% positive in FBC (P<0.04).
According to adjuvant
treatment there were significant differences between MBC and FBC.
There was no difference between MBC and FBC as regarding DFS.
The median DFS was 3.9 years for FBC versus 3.4 years for MBC.
In term of OS, the MBC had poor OS compared to FBC.
Conclusion
MBC outcome was inferior compared to FBC that may be due to the
differences in the biological behavior of MBC. More studies are
needed for further understand the differences between MBC and
FBC.
[Rehab F Mohamed. Comparison
between Male Breast Cancer and Female Breast Cancer,
Retrospective Study.
Cancer Biology
2017;7(3):21-25].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
4.
doi:10.7537/marscbj070317.04.
Keywords:
Male, female, breast, cancer, retrospective, study |
Full Text |
4
|
5
|
Phytochemistry and Cytotoxic Activity of Annonasquamosa
L. Fruit Pulpagainst Human Carcinoma Cell Lines
Salama M. El-Darier1
and Abdelhady, E. F.2
*1
Botany and Microbiology Department, Faculty of Science,
Alexandria University, Alexandria, Egypt
2
Botany Departments, Faculty of Arts and Sciences, Elmarj,
Benghazi University, Libya
*Email:
salama_eldarier@yahoo.com
Abstract:
It was argue
that the different parts of
Annonasquamosa
L. (English:
sugar
apple,
Arabic: gishta)
have been used for the treatment of various types of cancer
however; surgery, chemotherapy as well as radiotherapy still
remain the basis of treatment. The aim of the present study was
to determine the phytochemistry and anticancer potential of
ethanolic extract of fruit pulp of Annonasquamosa against
cervical (HELA), liver (HEPG2), prostate (PC3), lung (H1299 &
A549), larynx (HEP2), breast (MCF7) and intestine (CACO) cell
lines. Qualitative phytochemical screening was carried out using
the crude fruit pulp aqueous extract. Data revealed the presence
of glycosides, alkaloids, saponins, phytosterols, phenols,
flavonoids, terpenoids and tannins as well as acetogenins. The
extract exhibited a strong significant anticancer activity
against H1299 (IC50= 9.96), CACO (IC50=
25.32), HEP2 (IC50= 26.13) and PC3 (IC50=
26.66). Moderate action was exhibited for HELA (IC50=
38.09) and A549 (IC50= 39.60) while a weak
achievement was recorded for MCF7 (IC50= 351.73) and
HEPG2 (IC50= 587.96). The study may conclude that A.
squamosa fruit pulp may be applied as food supplement in
some cancer treatment protocols.
[Salama
M. El-Darier and Abdelhady, E. F..
Phytochemistry and Cytotoxic Activity of Annonasquamosa
L. Fruit Pulpagainst Human Carcinoma Cell Lines. Cancer Biology 2017;7(3):26-30].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
5.
doi:10.7537/marscbj070317.05.
Key words:Phytochemistry,
Annonasquamosa, Cancer cell lines, Ethanolic extract,
food supplements. |
Full Text |
5
|
6
|
The use of magnetic
nanoparticles in hyperthermia of Ehrlich tumor
Sahar E. Abo-Neima, Hussein A.
Motaweh, and Rahma M.Anany
Department of physics, Faculty of
Science, Damanhur University, Egypt.
Sahar_amr2002@yahoo.com
Abstract:
Hyperthermia has been in use for
many years, as a potential alternative method in cancer
treatment, and high frequency microwave radiation has been used
successfully to raise the tumor temperature to around 42oC
in superficial tumors without causing damage to surrounding
healthy tissues. In the present work a total of 60 male mice
weighing 20-25gm of 4-5 weeks of age will be used in all the
experiments. A suspension of 106 cells/ mL isolated
from Ehrlich ascites carcinoma in mice will be prepared. The
animals will be injected into the left flank with 0.2mL of this
suspension. When tumors reach approximately 5-10 mm in diameter,
mice will be randomly divided into nine groups, each of ten
namely from G1 to G9:1st group
which injected with phosphate buffer (control group). 2nd
group which mice bearing tumor without injection with magnetic
nanoparticles (MNPs) and without hyperthermia (Tumor).3rd
group which mice bearing tumor exposed to microwave
hyperthermia without injection of MNPs (MW). 4th
group which mice bearing tumor injected with ferric MNPs (FE)
without hyperthermia.5th group which mice bearing
tumor injected with ferric MNPs and exposed to microwave
hyperthermia (FE+MW).6th group which mice bearing
tumor injected with Nickel MNPs without hyperthermia (NI).7th
group which mice bearing tumor injected with MNPs and exposed to
microwave hyperthermia (NI+MM).8thgroup which mice
bearing tumor injected with MNPs without hyperthermia (CO).9th
group which mice bearing tumor injected with cobalt MNPs and
exposed to microwave hyperthermia (CO+MW). The results showed
that The transmission electron microscope (TEM) image shows that
the prepared magnetite nanoparticles are almost spherical shape.
The particles have tendency to aggregate because of their
magnetic properties. The average particle size as determine from
the histogram is ~ 20 nm for Fe and 100nm for Co and Ni. The
electron diffraction shows that the sample are completely
crystalline as confirmed from the x-ray diffraction (XRD) and
there was highly significant decreased in the normalized tumor
size with the different treatment modalities as compared with
the animal bearing tumor (control group). The very high
significant decreased for Ni+MW treatment was indicated i. e.
the treatment of ehrlich tumor with Ni+MW give us the most
inhibition for tumor size. From the histopathological study for
ehlich tumor where tumors were treated with MNPs and with NPs
+MW which exhibits tumor necrosis and fibrosis. It was concluded
that MNPs can penetrate tumor tissue and pass through gaps, are
able to remain in the tumor tissue and destroyed cancer cells.
[Sahar
E. Abo-Neima, Hussein A. Motaweh, and Rahma M. Anany
. The use of magnetic
nanoparticles in hyperthermia of Ehrlich tumor.
Cancer Biology
2017;7(3):31-37].
ISSN:
2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
6.
doi:10.7537/marscbj070317.06.
Keywords:
Ehlich tumor, microwave,
nanoparticles, TEM, XRD, histopathology |
Full Text |
6
|
7
|
Recent Advances in Cancer
Chemotherapy
Akefe, I.O., 1 Adamu,
A.M., 2 Yusuf, I.L 3
1.
Physiology Department, Faculty of Veterinary Medicine, Ahmadu
Bello University, Zaria
2.
Veterinary Teaching Hospital,
Faculty of Veterinary Medicine, University of Abuja
3.
Pharmacology and Toxicology Department, Faculty of Veterinary
Medicine, University of Maiduguri.
akefeisaac@yahoo.com, 08034986335, 08156353662
Abstract:
Conventional anticancer therapies
are deficient in the management of patients. This has led to the
need for alternative techniques developed to target tumour
cells. Recent therapies intended to replace conventional methods
include photodynamic therapy, human alpha-lactalbumin made
lethal to tumor cells, gene therapy, telomerase therapy,
hyperthermia therapy, complementary and alternative therapy,
diet therapy, insulin potentiating therapy and bacterial
treatment. However, these therapies are controversial due to
lack of evidence, efficacy, feasibility, availability,
specificity and selectivity. As a result, cancer still remains
as one of the diseases with extremely high mortality and as
such, adjunct and neoadjunct cancer chemotherapy remains the
main hope for cancer treatment. There is need to focus future
research on the development of more potent and less toxic cancer
chemotherapeutic agents from the vast array of natural and
synthetic compounds so as to improve health, prolong life and
reduce the high mortality associated with this epidemic.
[Akefe, I.O., Adamu, A.M., Yusuf,
I.L. Recent Advances in Cancer Chemotherapy.
Cancer Biology
2017;7(3):38-51].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
7.
doi:10.7537/marscbj070317.07.
Keywords:
Cancer, Health, Chemotherapy Antineoplastic |
Full Text |
7
|
8
|
Afla-Toxins and Carcinoma in
fish (Review)
Mona S. Zaki1; Mostafa F. Abdel Zaher1 and
Olfat Fawzy2
1Department of Hydrobiology, National Research Centre, Dokki,
Cairo, Egypt
2Department of Biochemistry, National Research Centre, Dokki,
Cairo, Egypt
dr_mona_zaki@yahoo.co.uk
Abstract: The influence of
dietary aflatoxins on body weight, immunity, and hormonal
profile was studied in fish.
The results revealed that decrease body weight, IgM, Insulin,
there is carcinoma in liver of fish suffered from Afla-toxins
may also induce an immunosuppressive effect on humoral immune
response of fish.
[Mona
S. Zaki ; Mostafa F. Abdel Zaher and
Olfat Fawzy
. Afla-Toxins and Carcinoma in fish (Review).
Cancer Biology
2017;7(3):52-54].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
8.
doi:10.7537/marscbj070317.08.
Key words:
Afla-Toxins,
Carcinoma, Fish. |
Full Text |
8
|
9
|
The Effect of Different Rates of Nitrogen and Plant Density on
Qualitative and Quantitative traits of Indian mustard
Sahar Keivanrad1, Babak Delkhosh1, Amir
Hossein Shirani Rad2, Peiman Zandi3
1Department
of Agronomy, Science and Research Branch, Islamic Azad
University, Tehran, Iran
2Associate
professor, Seed and Plant Improvement Institute, Karaj, Iran
2Department
of Agronomy, Takestan Branch, Islamic Azad University, Takestan,
Iran
z_rice_b@yahoo.com;
shirani.rad@gmail.com;
sahar.k1rad@yahoo.com
Abstract:
To understand the
effect of plant density and amounts of nitrogen fertilizer on
some agronomic characteristics of Indian mustard, an experiment
was laid out as a randomized complete block design with
split-plot arrangement with
three replications.
Nitrogen fertilizer levels (0, 50, 100, 150 and 200 kg N/ha)
were allotted to main plots and subplots were consisted of three
levels of plant densities (80, 100 and 120 plants/ m2).
The results indicated that, plant density had a highly
significant effect on
plant height, seed/siliqua, siliqua/plant,
seed yield,
biologic yield, 1000-seed weight, oil content and oil yield (p<0.01).
All tested traits (qualitative and quantitative ones) were
significantly affected by nitrogen fertilizer (p<0.01).
Nitrogen×plant
density interaction
also significantly affected all tested traits (p<0.05)
except for plant height and siliqua/plant. Our findings suggest
that for semi-arid zone of Takestan, Indian mustard due to its
high adaptation to arid conditions can be a good option for
spring rapeseed replacement.
[Sahar
Keivanrad, Babak Delkhosh, Amir Hossein Shirani Rad, Peiman
Zandi.
The Effect of Different Rates of Nitrogen and Plant Density on
Qualitative and Quantitative traits of Indian mustard. Cancer Biology 2017;7(3):55-62].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
9.
doi:10.7537/marscbj070317.09.
Keywords:
Brassica juncea;
plant population; nitrogen fertilizer; seed yield; oil yield;
oil content |
Full Text |
9
|
10
|
A New Method for Position
Control of a 2-DOF Robot Arm Using Neuro – Fuzzy Controller
Jafar Tavoosi*, Majid Alaei*,
Behrouz Jahani1, Muhammad Amin Daneshwar2
1Faculty
of Electrical and Computer Engineering, University of Tabriz,
Tabriz, Iran
2Department
of Electricel Engineering, Mahabad Branch, Islamic Azad
University, Mahabad, Iran
mdaneshwar@yahoo.com
Abstract:
Robot manipulators have become
increasingly important in the field of flexible automation. So
modeling and control of robots in automation will be very
important. But Robots, as complex systems, must detect and
isolate faults with high probabilities while doing their tasks
with humans or other robots with high precision and they should
tolerate the fault with the controller. This paper introduces a
Neuro-Fuzzy Controller (NFC) for position control of robot arm.
A five layer neural network is used to adjust input and output
parameters of membership function in a fuzzy logic controller.
The hybrid learning algorithm is used for training this network.
In this algorithm, the least square estimation method is applied
for the tuning of linear output membership function parameters
and the error backpropagation method is used to tune the
nonlinear input membership function parameters. The simulation
results show that neuro fuzzy controller is better and more
robust than the PID controller for robot trajectory control.
[Jafar
Tavoosi, Majid Alaei, Behrouz Jahani, Muhammad Amin Daneshwar.
A New Method for Position Control of a 2-DOF Robot Arm Using
Neuro – Fuzzy Controller
. Cancer Biology 2017;7(3):63-70].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
10.
doi:10.7537/marscbj070317.10.
Keywords:
Robot arm, Hybrid Learning, Neuro-Fuzzy Controller (NFC) |
Full Text |
10
|
11
|
Hela Cells and Immortality
Dr. Ma Hongbao
Brookdale University Hospital &
Medical Center, Brooklyn, NY 11212, USA
ma8080@gmail.com;
718-404-5362
Abstract:
Immortality
is
the eternal life, the ability to live forever. The most
important is the
biological immortality, where the living body will live without
die. Other people believe that
life extension is a more achievable goal in the short term, with
immortality awaiting further research breakthroughs.
HeLa is an immortal cell line
used in scientific researches and applications. It is the oldest
and most commonly used human cell line. The line was derived
from cervical cancer cells taken on February 8, 1951 from
Henrietta Lacks, a patient who died of her cancer on October 4,
1951. The cell line was found to be durable which let
researchers can use it in scientific research easily. The cells
from Lacks' cancerous cervical tumor were taken without her
knowledge or consent. Cell biologist George Otto Gey found that
the cells could be kept alive, and a single cell was isolated
then multiplied from them. Finally the cell was developed as a
cell line. This cell line was labeled as HeLa, the first two
letters of the patient's first and last name (Henrietta Lacks),
and the HeLa became the name of the cell line.
[Ma
H. Hela Cells and Immortality.
Cancer Biology
2017;7(3):71-78].
ISSN:
2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
11. doi:10.7537/marscbj070317.11.
Key words:
cancer; immortality; DNA; eternal; life; stem cell;
cell; protein |
Full Text |
11
|
12
|
Retrospective preliminary study on the magnitude of q-RT-PCR for
BCR-ABL over FISH BCR-ABL in follow up of CML patient receiving
First Line TKI Therapy
Mohammed Al-Sayegh1, 2, Hani Al
Hashmi1, Omar Abduljali1, Afra Al-Dayel3,
Khalid Al Anezi1, Panagiotis Kalogiannidi1,
Dina Soliman4,
Arwa Al Saber3,
Ali Al Matrok3, Mahmoud M Kamel4, Heba
N.Raslan3,4
1Adult Hemato-Oncology
and BMT Unit King Fahad Specialist Hospital Dammam, KSA
2King
Fahad Hospital Jeddah, KSA
3Laboratory Department
King Fahad Specialist Hospital Dammam, KSA
4Laboratory Department
National Cancer Institute Cairo University, Egypt
alsayegh59@yahoo.com,
hebaraslan2012@gmail.com,
mm.kamel@yahoo.com
Abstract:
Background:
The pathogenesis of Chronic Myelogenous leukaemia (CML) is
driven by the BCR-ABL1 fusion oncoprotein, a dysregulated
tyrosine kinase, that results from a reciprocal translocation
(9:22) (q34; q11) or Philadelphia chromosome (Ph). Over the past
decades, CML therapy has relied on specific tyrosine kinase
inhibitors (TKIs) whose success has established CML as a model
disease for targeted cancer treatment. The hall mark of CML
diagnosis and the efficacy of TKI therapy are confirmed by
cytogenetic and molecular investigations.
Objective:
Our study was to
compare the molecular and cytogenetic results in a cohort CML
patients receiving first line TKI therapy and determine whether
molecular testing has a better predictive value over cytogenetic
testing and to investigate whether molecular testing could be
solely as sufficient to monitor CML with limiting cytogenetic
testing used at to the diagnostic and resistance stages only.
Methods:
A total of 66 patients were included in the Imatinib treatment
regimen, of which 63 Patients had molecular and/or cytogenetic
data at at-least one specific time point.
Results and
Conclusion:
Molecular response could predict a subsequent cytogenetic
response while a CCyR milestone was not an effective indicator
of therapeutic progress in the patient cohort. Since a molecular
response was sufficient to determine treatment outcome in our
patient group, we propose to substitute the largely redundant
cytogenetic testing with the more sensitive and reproducible
molecular testing.
[Mohammed
Al-Sayegh, Hani Al
Hashmi, Omar Abduljali, Afra Al-Dayel, Khalid Al Anezi,
Panagiotis Kalogiannidi, Dina Soliman,
Arwa Al Saber, Ali Al
Matrok, Mahmoud M Kamel, Heba N. Raslan.
Retrospective
preliminary study on the magnitude of q-RT-PCR for BCR-ABL over
FISH BCR-ABL in follow up of CML patient receiving First Line
TKI Therapy. Cancer Biology
2017;7(3):79-89].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
12.
doi:10.7537/marscbj070317.12.
Key words:
CML, Molecular and cytogenetic response, Philadelphia chromosome
and TKI therapy |
Full Text |
12
|
13
|
|
Full Text |
13
|
The manuscripts in this
issue were presented as online first for peer-review starting
from
July 26, 2017.
All comments are
welcome:
editor@sciencepub.net,
or contact with
author(s) directly.
For
back issues of the Researcher,
click here.
Emails:
editor@sciencepub.net
|